These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19672033)

  • 1. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
    Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
    Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese.
    Yamazaki Y; Fujihara K; Sato T; Harada Yamada M; Yaguchi Y; Matsubayashi Y; Yamada T; Kodama S; Kato K; Shimano H; Sone H
    J Atheroscler Thromb; 2024 Apr; 31(4):382-395. PubMed ID: 37981330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waist circumference as a cardiovascular and metabolic risk in Japanese patients with type 2 diabetes.
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Ishibashi S; Oikawa S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    Obesity (Silver Spring); 2009 Mar; 17(3):585-92. PubMed ID: 19023281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal waist circumference cut-off points and ability of different metabolic syndrome criteria for predicting diabetes in Japanese men and women: Japan Epidemiology Collaboration on Occupational Health Study.
    Hu H; Kurotani K; Sasaki N; Murakami T; Shimizu C; Shimizu M; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Nagahama S; Uehara A; Yamamoto M; Tomita K; Imai T; Nishihara A; Kochi T; Eguchi M; Miyamoto T; Hori A; Kuwahara K; Akter S; Kashino I; Kabe I; Liu W; Mizoue T; Kunugita N; Dohi S;
    BMC Public Health; 2016 Mar; 16():220. PubMed ID: 26939609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal cut-off of obesity indices to predict cardiovascular disease risk factors and metabolic syndrome among adults in Northeast China.
    Yu J; Tao Y; Tao Y; Yang S; Yu Y; Li B; Jin L
    BMC Public Health; 2016 Oct; 16(1):1079. PubMed ID: 27737656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome across Europe: different clusters of risk factors.
    Scuteri A; Laurent S; Cucca F; Cockcroft J; Cunha PG; Mañas LR; Mattace Raso FU; Muiesan ML; Ryliškytė L; Rietzschel E; Strait J; Vlachopoulos C; Völzke H; Lakatta EG; Nilsson PM;
    Eur J Prev Cardiol; 2015 Apr; 22(4):486-91. PubMed ID: 24647805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five year study of cardiovascular risk factors in Japanese people: implications concerning new onset of metabolic syndrome.
    Suzuki A; Kosuge K; Nanyu O; Watanabe H; Watanabe T; Usuda Y; Sasaki S; Aizawa Y
    Intern Med; 2010; 49(1):1-6. PubMed ID: 20045994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
    Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
    Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
    Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?
    Yasuda T; Matsuhisa M; Fujiki N; Sakamoto F; Tsuji M; Fujisawa N; Kimura M; Ishibashi R; Kaneto H; Yamasaki Y; Watarai T; Imano E
    Endocr J; 2007 Dec; 54(5):695-702. PubMed ID: 17785919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.
    Dehghan A; Jahangiry L; Khezri R; Jafari A; Pezeshki B; Rezaei F; Aune D
    BMC Endocr Disord; 2024 Jun; 24(1):95. PubMed ID: 38915041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and its predictors in an urban population in Kenya: A cross sectional study.
    Omuse G; Maina D; Hoffman M; Mwangi J; Wambua C; Kagotho E; Amayo A; Ojwang P; Premji Z; Ichihara K; Erasmus R
    BMC Endocr Disord; 2017 Jul; 17(1):37. PubMed ID: 28676116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Combined Obesity Indices to Predict Cardiovascular Diseases Risk Factors and Metabolic Syndrome in Northeast China.
    Tao Y; Yu J; Tao Y; Pang H; Yu Y; Yu Y; Jin L
    Int J Environ Res Public Health; 2016 Aug; 13(8):. PubMed ID: 27517940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North Indian Diabetes and Cardiovascular Disease Study-NIDCVD-2.
    Bhatti GK; Bhadada SK; Vijayvergiya R; Mastana SS; Bhatti JS
    J Diabetes Complications; 2016; 30(1):72-8. PubMed ID: 26271411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peri-implant diseases and metabolic syndrome components: a systematic review.
    Papi P; Letizia C; Pilloni A; Petramala L; Saracino V; Rosella D; Pompa G
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):866-875. PubMed ID: 29509232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Models Predictive of Metabolic Syndrome Components in Obese Pediatric Patients.
    Ortega-Cortes R; Trujillo X; Hurtado López EF; López Beltrán AL; Colunga Rodríguez C; Barrera-de Leon JC; Tlacuilo-Parra A
    Arch Med Res; 2016 Jan; 47(1):40-8. PubMed ID: 26820798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of two metabolic syndrome definitions in the estimation of cardiovascular disease among hypertensive patients.
    Hirota AH; Rodrigues CJ; Borges RL; Ribeiro AB; Zanella MT; Batista MC
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):588-96. PubMed ID: 20695935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.